| Exhibitor Set Up |
12:00 PM - 10:00 PM |
| Registration Open Present Your Photo ID |
11:30 AM - 8:00 PM |
| Private Meeting Rooms Open |
12:00 PM - 8:00 PM |
| The 4 Workshops Are Open to All Registered Attendees and Exhibitors. |
|
Workshop 1
CRDMO Supplier Selection & Negotiation for Emerging Pharma CMC |
2:00 PM - 5:00 PM |
Deb Minor
President
Drug Discovery Alliances
|
Sean Bradley
Vice President of Business Development
GL Chemtec International
|
James Kanter
Principal
K2 CMC
|
Michael Humora
Director
Apex Scientific Inc
|
Mathew Yanik
Associate Director, API
Intercept Pharmaceuticals
|
Mathew Yanik
Associate Director, API
Intercept Pharmaceuticals
|
|
|
Workshop 2
Strategies for Emerging Pharma: Aligning Your CMC, Nonclinical, and Regulatory Activities from Lead Selection Through Phase II |
2:00 PM - 5:00 PM |
Kevin Kane, Ph.D.
CMC Strategy Director
PPD Strategic Development Consulting
|
Ray Forslund, Ph.D.
SVP, Head of CMC Development & Project Management
Syner-G BioPharma Group
|
Duu-Gong Wu, Ph.D.
Executive Director, Regulatory and CMC Consulting
PPD Strategic Development Consulting
|
Matt Frizzle, MSc
Sr. Business Manager - Small Molecule API
Patheon by ThermoFisher
|
|
|
Workshop 3
Discovery Chemistry & Medical Chemistry Workshop |
1:00 PM - 4:00 PM |
| This workshop will focus on the medicinal chemistry supplier selection and relationship management strategies for innovator pharma companies. Should you use domestic or offshore suppliers, or both? What are the cost considerations? Should you contract a boutique supplier or one part of a CDMO? Domestic of multinational? FTE vs FFS contracts? Risk-sharing options? Thought leadership vs execution efficiency and effectiveness – can you have both? Rational choice vs gamble? IP considerations? So many questions to consider but you will have three hours, at least, to work through the scenarios.
The workshop is specially designed for medicinal chemists from innovator pharmaceutical companies who are interested in discussing strategies and comparing best practices with fellow colleagues from other companies. |
Paul Kim
Director of Medicinal Chemistry, Chemistry
AAPharmaSyn, LLC
|
Ruslan Pryadun
President, Chemistry
AAPharmaSyn, LLC
|
|
|
|
Workshop 4
Establishing A Preferred Supplier Network |
12:00 PM - 4:00 PM |
Malcolm Rosenthal
Consultant
Phlow Corporaton
|
George Regan
Global Sourcing Leader, API
Pfizer (Retired)
|
Jim Bruno
Owner
Chemical & Pharmaceutical Solutions
|
Robert Miller
VP
AbbVie (Retired)
|
Greg Bello
Principal
Greg Bello Consulting
|
|
|
Panel Discussion
What’s Going On With Demand for Small Molecule Chemistry Services? |
5:00 PM - 5:45 PM |
| Have you been wondering about the current market climate for small molecule chemistry services? With the strong emphasis on large molecules and advanced therapeutic modalities, what is the current demand and future outlook for small molecule chemistry services? Join our all-star panel of industry experts from Investment Banking, Emerging Pharma, and the CDMO community who will discuss their views on what’s happening with the current funding/economic climate, reshoring, and hot technology trends. |
Brian Scanlan (Moderator)
Operating Partner, Life Science
Edgewater Capital Partners
|
Kevin Hunt, Ph.D. (Panel)
Chief Scientific Officer
Vanqua Bio
|
Chris Conway (Panel)
President, Research & Development
Curia
|
Vincenzo Di Nicola (Panel)
Managing Director, Healthcare Investment Banking
Piper Sandler Ltd.
|
Adam Kujath (Panel)
Executive Vice President & Site Head (Panel)
Sterling Pharma Solutions
|
|
| Speakeasy Night at Parsippany Hilton - Drinks, Food, Karaoke, Fun – All Registered Attendees & Exhibitors Welcome |
6:00 PM - 8:30 PM |
